US company Novavax begins human trials of coronavirus vaccine in Australia

A US biotechnology company Novavax announced on Tuesday that the human trials of a coronavirus vaccine will begin in Australia. The company hopes to release a proven vaccine this year. According to the company’s research chief Dr. Gregory Glenn, Novavax has begun the first phase of the trial in which 131 volunteers in the cities of Melbourne and Brisbane will test the safety of the vaccine and look for early signs of the vaccine’s effectiveness.

A US biotechnology company Novavax announced on Tuesday that the human trials of a coronavirus vaccine will begin in Australia. The company hopes to release a proven vaccine this year. According to the company’s research chief Dr. Gregory Glenn, Novavax has begun the first phase of the trial in which 131 volunteers in the cities of Melbourne and Brisbane will test the safety of the vaccine and look for early signs of the vaccine’s effectiveness. May 26, 2020 at 07:40AM https://ift.tt/2LYejnd